The maker of Panadol and Advil reported a 2.2% increase in first-quarter sales, missing expectations. The result was driven by lower-than-expected demand for seasonal cold and flu medications.
- Sales growth of 2.2% missed the 2.4% forecast
- Weak demand for OTC cold and flu medicines cited as primary cause